Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

BearDownAZ

Jun 22, 2020 07:26AM

Cottenmouth

Rank: Vice President [?]

Points: 844 [?]

Votes: 11 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

in response to

Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

BearDownAZ

posted on Jun 22, 2020 07:41AM

Woo hoo. Finally. Is today our day? The start of positive news going forward? Here's hoping.

8 Recommendations

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

fishtail

Jun 22, 2020 08:39AM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

KOO-KOO2

Jun 22, 2020 10:43AM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

KOO-KOO2

Jun 22, 2020 10:56AM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

SanFrancisco99

Jun 22, 2020 11:51AM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

SanFrancisco99

Jun 22, 2020 01:19PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

dutchfella

Jun 22, 2020 02:16PM

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

Jun 22, 2020 06:21PM

Jun 22, 2020 09:21PM

Back To Forum List View

Please to post a reply